This Funding Opportunity Announcement (FOA) invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to simultaneously address a targeted research question in brain aging and Alzheimer's disease (AD), including AD-related dementias (ADRD).
This FOA utilizes the R21/R33 Phased Innovation Award activity code. The R21 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.
The aim of this initiative is for investigators to develop a sustainable, interdisciplinary collaboration across experimental and computational laboratories to support projects that address key research questions in brain aging and AD/ADRD.
Deadlines:
Letter of Intent Due Date(s): August 22, 2023
Application Due Date: September 22, 2023
RFA-AG-24-018 Expiration Date September 23, 2023
For the R21 phase, the combined budget for direct costs for a two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
For the R33 phase, application budgets must remain under $500,000 in annual direct costs.
